DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Bramhall SR, Schulz J, Nemunaitis J. et al.
A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer.
Br J Cancer 2002; 87: 161-167
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.